Who is sponsoring NCT04038021?

NCT04038021 is sponsored by Washington State University.

What condition does NCT04038021 study?

NCT04038021 studies Alcohol Use Disorder.

Is NCT04038021 still recruiting?

NCT04038021 is currently completed. Last updated 27 April 2023.

Last reviewed 2023-04-27 · How we verify

NCT04038021

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Phosphatidylethanol-Based Contingency Management for Housing

Completed NA Last updated 27 April 2023

What this trial tests

NA trial testing Phosphatidylethanol-based Contingency Management in Alcohol Use Disorder in 17 participants. Completed in 27 October 2022.

Timeline

13 January 2020

Primary endpoint
23 August 2022

27 October 2022

Quick facts

Lead sponsor	Washington State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	17
Start date	13 January 2020
Primary completion	23 August 2022
Estimated completion	27 October 2022
Sites	1 location across United States

Drugs / interventions tested

Phosphatidylethanol-based Contingency Management
Non-Contingent Control

Conditions studied

Alcohol Use Disorder — all drugs for Alcohol Use Disorder →

Sponsor

Washington State University

Who can join

18 and older, any sex, with Alcohol Use Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will evaluate the efficacy of contingency management (CM) in reducing alcohol use in individuals experiencing unstable housing but who are currently housed in shelters. Participants will be 20-30 adults diagnosed with alcohol use disorder (AUD) and has a history or unstable housing or literal homelessness in the last year but is currently receiving housing through Catholic Charities Spokane or other locations. Individuals who demonstrate AUD and have measurable PEth \>ng/mL at the baseline visit will be randomized to receive Phosphatidylethanol-based CM treatment or non-contigent treatment.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Mixed-methods trial of a phosphatidylethanol-based contingency management intervention to initiate and maintain alcohol abstinence in formerly homeless adults with alcohol use disorders.
Fraser ER, Hill-Kapturczak N, Jett J, Beck R, et al · · 2021 · cited 6× · PMID 33763620 · DOI 10.1016/j.conctc.2021.100757
Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial.
Jett JD, Beck R, Tyutyunnyk D, Sanchez J, et al · · 2024 · cited 4× · PMID 38284925 · DOI 10.1080/00952990.2023.2283691

Verify or expand the search:

Other recruiting trials for Alcohol Use Disorder

Currently open trials in the same condition.

NCT06860607 — Environment and Alcohol: A Pilot Study · Phase 1 · recruiting
NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting

Other Washington State University trials

Trials by the same sponsor.

NCT07088237 — Testing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery (CalmiFy II) · NA · not yet recruiting
NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
NCT07171359 — TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD) · NA · not yet recruiting
NCT07052318 — Developing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery · recruiting
NCT06804239 — Improving Activity in Adults With Chronic Pain With Online Resources · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04038021 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Washington State University
Last refreshed: 27 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04038021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing